Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Grupo Español de Investigación en Neurooncología.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Grupo Español de Investigación en Neurooncología
ClinicalTrials.gov Identifier:
NCT01308632
First received: January 24, 2011
Last updated: March 2, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)